Be part of the green revolution happening within the bioeconomy industries. The Bachelor of Science degree in Bioprocess Engineering prepares students for an exciting career where they can make an ...
The bioprocess science minor gives students an understanding of the rapidly developing bioprocessing industry, which uses the chemical, physical and biological processes developed by living organisms ...
Shares of 908 Devices (NASDAQ:MASS) climbed ~71% in the premarket on Tuesday after Repligen (NASDAQ:RGEN) offered $70M in ...
Sartorius invests in new production line in Bengaluru to meet global demands, doubling capacity for chromatography systems.
Repligen (RGEN), and 908 Devices (MASS) announced that Repligen has purchased 908 Devices’ desktop portfolio of four devices for bioprocessing ...
Turning silver nanoparticles into commercial products could create a faster pathway to new antimicrobials and cancer treatments.
The journey to develop an upstream bioprocess is complex, involving process development, optimization and scale-up. Hence, it’s important to choose the right equipment to accelerate this journey while ...
Repligen Corp. acquired 908 Devices Inc.’s desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications for $70 million in cash.
Dublin, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The "Bioprocess Containers - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The latest insights into the Bioprocess ...
Repligen Corporation acquired 908 Devices’ desktop portfolio of 4 devices for bioprocessing process analytical technology (PAT) applications.
The monetary consideration of Repligen's purchase of 908 Devices' bioprocess analytics portfolio is a payment of $70 million in cash.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results